Indeed, compared to healthy control (HC), AD patients have the following three characteristics: (1) higher protein level of KLKs in stratum corneum [13], (2) significant decrease in the expression of SPINK5 encoding LEKTI [14], and (3) higher pH level [15], [16], all of which result in higher KLK activity. This evidence concerns the gene SPINK5 and Alzheimer disease.